Clinical Trial Update: Systemic and Local Levels of Lidocaine During Surgery for the Removal of Glioblastoma [Phase 1]

View source ↗

Summary

A Phase 1 study by UC Davis evaluated systemic and local lidocaine levels during glioblastoma surgery; the trial is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Lidocaine (Lidocaine)

Snippet

Sponsor: University of California, Davis | Conditions: Glioblastoma | Phase 1 | Status: COMPLETED